Polycystic ovary syndrome is a hormonal disorder observed in females of reproductive ages. The disorder causes the excessive production of hormones in the female body, which include testosterone or androgens, hormones that are primarily associated with the male reproductive system. PCOS includes a range of symptoms such as irregular menstrual cycle, trouble in getting pregnant, cyst formation in the ovaries, excessive body and facial hair, and pelvic pain, among others. Moreover, the early diagnosis of the disorder is highly recommended by the physicians, as untreated PCOS may often lead to high cholesterol, type-2 diabetes, heart disease, insulin resistance, and high blood pressure. Major factors contributing to the growth of the global polycystic ovary syndrome market include sedentary lifestyle and faulty dietary habits and increasing female obese population across the globe. Initiatives taken by the government and non-profit organizations to spread awareness regarding the early diagnosis of the disorder is significantly fueling the market growth. Moreover, increasing genetic and hormonal disorder in female population is a major cause for the increase of polycystic ovary syndrome patients across the globe. Lack of regulatory approved drugs for the treatment of PCOS and easy availability of generic and off-label drugs may restrain the growth of the global PCOS market. However, market players are focusing in the development of innovative and symptom specific drugs are expected to fuel the market growth in the near future.
Request a free sample of our report on Global Polycystic Ovary Syndrome Market: https://www.omrglobal.com/request-sample/pcos-polycystic-ovary-syndrome-market
The polycystic ovary syndrome market can be segmented on the basis of drug type, diagnosis type, treatment type, and distribution channel. Based on drug type, the market is segmented into diuretics, insulin sensitizing agents, antiandrogens, anti-depressants, ornithine decarboxylase inhibitors, anti-obesity, and oral contraceptive pills. Based on diagnosis type, the market is bifurcated into ultrasound, pelvic exam, and blood tests. Based on treatment type, the market is segmented into ovarian wedge resection, laparoscopic ovarian drilling, and acupuncture. Based on distribution channel, the market is diversified into hospital pharmacies, drug stores, retail pharmacies, fertility clinics, and e-commerce. Among type of drugs, the insulin-sensitizing agents segment holds a major share in the polycystic ovary syndrome market. This is owing to wide adoption of the drug for the treatment of insulin resistance, to prevent diabetes.
A full report of Global Polycystic Ovary Syndrome Market Is available at https://www.omrglobal.com/industry-reports/pcos-polycystic-ovary-syndrome-market
Global Polycystic Ovary Syndrome Market Segmentation
By drug type
Diuretics
Insulin sensitizing agents
Antiandrogens
Anti-depressants
Ornithine decarboxylase inhibitors
Anti-obesity
Oral contraceptive pills
By diagnosis type
Ultrasound
Pelvic exam
Blood test
By treatment type
Ovarian wedge resection
Laparoscopic ovarian drilling
Acupuncture
By distribution channel
Hospital pharmacies
Retail pharmacies (online and offline)
Fertility clinics
Competitive landscape
Key company analysis
Key strategy analysis
Regional analysis
North american
United states
Canada
Europe
U.k
Germany
Italy
Spain
France
Roe
Asia pacific
India
China
Japan
Roapac
Rest of the world
Company profiles
Abbott laboratories
Addex therapeutics
Anax
Astellas pharma, inc.
Astrazeneca
Ava science inc.
Bayer ag
Bristol-myers squibb company
Dexa medica
Ferring pharmaceuticals
For more customized data, request for report customization @ https://www.omrglobal.com/report-customization/pcos-polycystic-ovary-syndrome-market
About Us:
Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting, and other research-based services.

For More Information, Visit https://www.omrglobal.com/

Media Contact:
Company Name: Orion Market Research
Contact Person: Mr. Anurag Tiwari
Email: [email protected]
Contact no: +91 780-304-0404